Tumor extracellular vesicle–derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming
Science Translational Medicine · 12.02.2025 · 17 (785)
DOI: 10.1126/scitranslmed.adm7269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 12.02.2025. Verfasst von Feiya Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO…. Hauptthemen laut MEDLINE: Extracellular Vesicles, B7-H1 Antigen, Cellular Senescence, T-Lymphocytes. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
The limited success of cancer immunotherapy has posed challenges in treating patients with cancer. However, promising strides could be made with a deeper understanding of the factors that cause T cell dysfunction within the tumor microenvironment and by developing effective strategies to counteract tumor-induced immune suppression. Here, we report that tumor-derived extracellular vesicles (tEVs) can induce senescence and suppression in T cells. Programmed death ligand 1 (PD-L1), a key component within tEVs, induced DNA damage and hyperactive lipid metabolism in both human and mouse T cells. This caused an elevated expression of lipid metabolic enzymes and an increase in cholesterol and lipid droplet formation, leading to cellular senescence. At a molecular level, PD-L1 derived from tEVs activated the cAMP-response element binding protein (CREB) and signal transducer and activator of transcription (STAT) signaling, which promoted lipid metabolism and facilitated senescence in human and mouse T cells. Inhibiting EV synthesis in tumors or blocking CREB signaling, cholesterol synthesis, and lipid droplet formation in effector T cells averted the tEV-mediated T cell senescence in vitro and in vivo in cell adoptive transfer and melanoma mouse models. The same treatments also bolstered the antitumor efficacy of adoptive transfer T cell therapy and anti–PD-L1 checkpoint immunotherapy in both human and mouse melanoma models. These studies identified mechanistic links between tumor-mediated immune suppression and potential immunotherapy resistance, and they provide new strategies for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA.
- Department of Biology, Saint Louis University, St. Louis, MO 63103, USA.
- Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA.
- Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO 63110, USA.
- Department of Pathology & Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
ORCID-Profile: Feiya Ma, Xia Liu, Yuanqin Zhang, Lei Zhao, Cody Huffman, Sidharth V Puram, Yuqi Wang, Guangyong Peng
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Ma, F., Liu, X., Zhang, Y., Tao, Y., Zhao, L., Abusalamah, H., Huffman, C., Harbison, R. A., Puram, S. V., Wang, Y., & Peng, G. (2025). Tumor extracellular vesicle–derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming. Science Translational Medicine, 17(785). https://doi.org/10.1126/scitranslmed.adm7269
Vancouver
Ma F, Liu X, Zhang Y, Tao Y, Zhao L, Abusalamah H, et al. Tumor extracellular vesicle–derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming. Science Translational Medicine. 2025;17(785). doi:10.1126/scitranslmed.adm7269
BibTeX
@article{Ma2025,
author = {Ma, Feiya and Liu, Xia and Zhang, Yuanqin and Tao, Yan and Zhao, Lei and Abusalamah, Hazar and Huffman, Cody and Harbison, R Alex and Puram, Sidharth V and Wang, Yuqi and Peng, Guangyong},
title = {Tumor extracellular vesicle–derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {785},
doi = {10.1126/scitranslmed.adm7269}
}
EUVIMED